Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

04 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/04/3212404/0/en/Crinetics-Pharmaceuticals-to-Provide-PALSONIFY-Business-Update-and-Announce-Topline-Results-from-Fourth-Cohort-of-Phase-2-Trial-of-Atumelnant-in-Congenital-Adrenal-Hyperplasia.html

18 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/18/3208172/0/en/Crinetics-Pharmaceuticals-to-Participate-in-The-44th-Annual-J-P-Morgan-Healthcare-Conference.html

11 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/11/3204301/0/en/Crinetics-Announces-First-Patient-Dosed-in-Pivotal-Adult-Trial-of-Atumelnant-in-Congenital-Adrenal-Hyperplasia-CAH.html

10 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/10/3203529/0/en/Crinetics-Pharmaceuticals-Announces-December-2025-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

03 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/03/3198798/0/en/Crinetics-Announces-First-Patient-Dosed-in-Phase-1-2-Trial-Evaluating-CRN09682-for-the-Treatment-of-Neuroendocrine-Tumors-and-Other-Somatostatin-Receptor-2-Expressing-Tumors.html

20 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/20/3192379/0/en/Crinetics-Announces-First-Patient-Randomized-in-Pivotal-Phase-3-CAREFNDR-Trial-Evaluating-Paltusotine-in-Carcinoid-Syndrome.html
ABOUT THIS PAGE